These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 28295152)

  • 1. Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.
    Finsterer J; Wanschitz J; Quasthoff S; Iglseder S; Löscher W; Grisold W
    Acta Neurol Scand; 2017 Dec; 136(6):558-569. PubMed ID: 28295152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary transthyretin-related amyloidosis.
    Finsterer J; Iglseder S; Wanschitz J; Topakian R; Löscher WN; Grisold W
    Acta Neurol Scand; 2019 Feb; 139(2):92-105. PubMed ID: 30295933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathy Associated with Systemic Amyloidosis.
    Kaku M; Berk JL
    Semin Neurol; 2019 Oct; 39(5):578-588. PubMed ID: 31639841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deterioration after Liver Transplantation and Transthyretin Stabilizer Administration in a Patient with ATTRv Amyloidosis with a Leu58Arg (p.Leu78Arg) TTR Variant.
    Hikishima S; Sakai K; Akagi A; Yamaguchi H; Shibata S; Hayashi K; Nakano H; Kanemoto M; Usui Y; Taniguchi Y; Komatsu J; Nakamura-Shindo K; Nozaki I; Hamaguchi T; Ono K; Iwasa K; Yamada M
    Intern Med; 2022 Aug; 61(15):2347-2351. PubMed ID: 35283385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of small fiber neuropathy: A comparative study of five neurophysiological tests.
    Lefaucheur JP; Wahab A; Planté-Bordeneuve V; Sène D; Ménard-Lefaucheur I; Rouie D; Tebbal D; Salhi H; Créange A; Zouari H; Ng Wing Tin S
    Neurophysiol Clin; 2015 Dec; 45(6):445-55. PubMed ID: 26596193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Role of In Vivo Confocal Microscopy for Imaging Corneal Nerves in Transthyretin Familial Amyloid Polyneuropathy.
    Rousseau A; Cauquil C; Dupas B; Labbé A; Baudouin C; Barreau E; Théaudin M; Lacroix C; Guiochon-Mantel A; Benmalek A; Labetoulle M; Adams D
    JAMA Ophthalmol; 2016 Sep; 134(9):983-9. PubMed ID: 27367055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
    Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L
    J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study.
    Planté-Bordeneuve V; Gorram F; Salhi H; Nordine T; Ayache SS; Le Corvoisier P; Azoulay D; Feray C; Damy T; Lefaucheur JP
    J Neurol; 2017 Feb; 264(2):268-276. PubMed ID: 27878441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Fabry disease and Hereditary ATTR amyloidosis in idiopathic small-fiber and mixed neuropathy.
    Samuelsson K; Radovic A; Press R; Auranen M; Ylikallio E; Tyynismaa H; KäRppä M; Veteläinen M; Peltola N; Mellgren SI; Mygland Å; Tallaksen C; Andersen H; Terkelsen AJ; Fontain F; Hietaharju A
    Muscle Nerve; 2019 Mar; 59(3):354-357. PubMed ID: 30246259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in the understanding and treatment of transthyretin amyloidosis.
    Sekijima Y
    J Clin Pharm Ther; 2014 Jun; 39(3):225-33. PubMed ID: 24749898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise".
    Grandis M; Geroldi A; Gulli R; Manganelli F; Gotta F; Lamp M; Origone P; Trevisan L; Gemelli C; Fabbri S; Schenone A; Tozza S; Santoro L; Bellone E; Mandich P
    Orphanet J Rare Dis; 2018 Oct; 13(1):177. PubMed ID: 30286783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients.
    Cappellari M; Cavallaro T; Ferrarini M; Cabrini I; Taioli F; Ferrari S; Merlini G; Obici L; Briani C; Fabrizi GM
    J Peripher Nerv Syst; 2011 Jun; 16(2):119-29. PubMed ID: 21692911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy.
    Dardiotis E; Kyriakides T
    Curr Neuropharmacol; 2023; 21(3):471-481. PubMed ID: 36366846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).
    Gonzalez-Duarte A
    Clin Auton Res; 2019 Apr; 29(2):245-251. PubMed ID: 29511897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis.
    Hund E
    Appl Clin Genet; 2012; 5():37-41. PubMed ID: 23776379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
    Salvi F; Volpe R; Pastorelli F; Bianchi A; Vella A; Rapezzi C; Mascalchi M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e212-e214. PubMed ID: 29779881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
    Murakami T; Nishimura H; Nagai T; Hemmi S; Kutoku Y; Ohsawa Y; Sunada Y
    J Neurol Sci; 2017 Oct; 381():55-58. PubMed ID: 28991715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis.
    Masuda T; Misumi Y; Nomura T; Yamakawa S; Tasaki M; Obayashi K; Ando Y; Ueda M
    Muscle Nerve; 2024 Jan; 69(1):99-102. PubMed ID: 37960924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.